Lexiva, Telzir (fosamprenavir) is a small molecule pharmaceutical. Fosamprenavir was first approved as Lexiva on 2003-10-20. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections.
|Indication||acquired immunodeficiency syndrome, hiv infections|
|Drug Class||Antivirals: HIV protease inhibitors (saquinavir type); phosphoro-derivatives|